New staff chief for von E
This article was originally published in The Rose Sheet
Executive Summary
Three months after moving to FDA from the American Pharmacists Association (APA) Susan Winckler is named acting chief of staff for FDA Commissioner Andrew von Eschenbach. Winckler, an attorney, joined FDA in September 2006 as policy communications director in the commissioner's Office of Policy & Planning, where she was the point person for constituent communications and policy development relevant to FDA advisory committees. Starting in January 2007, Winckler will coordinate staff activities and be the principal liaison to HHS. The Senate confirmed von Eschenbach as FDA commissioner Dec. 7 (1"The Rose Sheet" Dec. 11, 2006, p. 10)...
You may also be interested in...
Acting Commissioner Von Eschenbach Made Permanent In Time For New Year
Andrew von Eschenbach can delete "acting" from his office nameplate; the Senate confirmed him as FDA commissioner Dec. 7 by a comfortable 80-11 margin, ending months of "holds" on the vote and opposition to his nomination from both sides of the aisle
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.